Barclays raised the firm’s price target on Corebridge (CRBG) to $36 from $34 and keeps an Equal Weight rating on the shares. The company’s operating earnings comes in ahead of estimates on strong performance from Life Insurance and solid results in all other segments, the analyst tells investors in a research note.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter